Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Alaunos Therapeutics (TCRT) over the last 14 years, with Q3 2025 value amounting to $942000.0.

  • Alaunos Therapeutics' Other Non-Current Assets changed N/A to $942000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $942000.0, marking a year-over-year change of. This contributed to the annual value of $500000.0 for FY2022, which is 2076.07% down from last year.
  • According to the latest figures from Q3 2025, Alaunos Therapeutics' Other Non-Current Assets is $942000.0.
  • Alaunos Therapeutics' 5-year Other Non-Current Assets high stood at $13.9 million for Q3 2022, and its period low was $185000.0 during Q1 2021.
  • In the last 4 years, Alaunos Therapeutics' Other Non-Current Assets had a median value of $626000.0 in 2022 and averaged $2.7 million.
  • As far as peak fluctuations go, Alaunos Therapeutics' Other Non-Current Assets crashed by 7222.22% in 2021, and later surged by 370821.92% in 2022.
  • Over the past 4 years, Alaunos Therapeutics' Other Non-Current Assets (Quarter) stood at $631000.0 in 2021, then fell by 20.76% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then surged by 88.4% to $942000.0 in 2025.
  • Its Other Non-Current Assets was $942000.0 in Q3 2025, compared to $997000.0 in Q2 2025 and $1.1 million in Q1 2025.